Patrick J. Creaven - Concepedia

Author

Patrick J. Creaven

Roswell Park Comprehensive Cancer Center

Also Known As

H G Vogt, P CREAVEN, P Creaven, P J Creaven, P. Creaven, P. J. CREAVEN, P. J. Creaven, P.J. Creaven, Patrick Creaven, Patrick J Creaven

150

Publications

4.8K

Citations

H-Index

130

Concepts

All Affiliations

Roswell Park Comprehensive Cancer Center United States Department of Veterans Affairs Texas Research Institute

About

Patrick J. Creaven is an author at Roswell Park Comprehensive Cancer Center specializing in medicine, pharmacology, and pharmacotherapy.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	33	60	3.6K
2	Biochemistry	12	16	441
3	Health Sciences	10	11	788
4	Natural Sciences	8	8	198
5	Biology	1	1	10

Patrick J. Creaven

Publications

4.2K

Citations

H-Index

Page 1

	Year	Citations
A prospective randomized trial of 5-fluorouracil versus 5-fluorouracil and high-dose leucovorin versus 5-fluorouracil and methotrexate in previously untreated patients with advanced colorectal carcinoma. Nicholas J. Petrelli, L Herrera, Youcef M. Rustum, Journal of Clinical Oncology OncologyPharmacologyClinical TrialsColorectal CancerIv Hydration	1987	449
Phase I clinical trial of weekly and daily treatment with camptothecin (NSC-100880): correlation with preclinical studies. Franco M. Muggia, Patrick J. Creaven, H.H. Hansen, PubMed Therapeutic Drug MonitoringTranslational MedicinePreclinical StudiesPharmacologyPharmacotherapy	1972	313
Intensive chemotherapy of small cell bronchogenic carcinoma. Martin H. Cohen, Patrick J. Creaven, Byron E. Fossieck, PubMed MedicineChemotherapyIntensive Induction ChemotherapyPathologyExtensive Disease	1977	251
In vitro cytotoxicity, protein binding, red blood cell partitioning, and biotransformation of oxaliplatin. Lakshmi Pendyala, Patrick J. Creaven PubMed Whole BloodGliomaRedox BiologyTumor BiologyOxidative Stress	1993	208
Phase I-II trial of high-dose calcium leucovorin and 5-fluorouracil in advanced colorectal cancer. Stefan Madajewicz, Nicholas J. Petrelli, Youcef M. Rustum, PubMed Gastrointestinal PharmacologyGastroenterologyPathologyPharmacotherapyAdvanced Colorectal Cancer	1984	156
Initial clinical (phase I) trial of TLC D-99 (doxorubicin encapsulated in liposomes). J. Wayne Cowens, Patrick J. Creaven, William R. Greco, PubMed Cardiovascular ToxicityLipid PreparationTlc D-99Drug TargetingMedicine	1993	136
Clinical pharmacological studies of concurrent infusion of 5-fluorouracil and thymidine in treatment of colorectal carcinomas. J. Lai‐Sim Au, Youcef M. Rustum, Elihu J. Ledesma, PubMed Surgical OncologyClinical Pharmacological StudiesPathologyPharmacotherapyConcurrent Infusion	1982	110
Comparison of the human pharmacokinetics of VM-26 and VP-16, two antineoplastic epipodophyllotoxin glucopyranoside derivatives Larry M. Allen, Patrick J. Creaven European Journal of Cancer (1965) Pharmaceutical ScienceHuman PharmacokineticsMedicinePharmacotherapyDrug Development	1975	109
Characterization of cells obtained by mechanical and enzymatic means from human melanoma, sarcoma, and lung tumors. Harry K. Slocum, Zlatko P. Pavelić, Youcef M. Rustum, PubMed Cell CultureBiomedical EngineeringMechanical ReleaseCancer BiologyCellular Physiology	1981	97
A Phase I Pharmacokinetic and Pharmacodynamic Study of Intravenous Calcitriol in Combination with Oral Gefitinib in Patients with Advanced Solid Tumors Marwan Fakih, Donald L. Trump, Josephia R. Muindi, Clinical Cancer Research	2007	90

Page 1